In the last five years, a few studies have appeared showing that the neuron-specific postsynaptic protein neurogranin (which is mainly expressed in regions affected in AD like cortex, hippocampus and amygdala) is higher in AD patients and this increase seems specific of AD as it is not seen in other neurodegenerative diseases. Here, NRGN is linked to Alzheimer disease.